Skip to main content
RCEL
NASDAQ Industrial Applications And Services

AVITA Medical Appoints Seasoned Healthcare Executive Joe Woody to Board of Directors

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.47
Mkt Cap
$105.811M
52W Low
$3.25
52W High
$14.16
52W Position info
6.8% above low
Off High info
75% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

RCEL is trading near its 52-week low of $3.25 (6.8% above the low).

Summary

AVITA Medical appointed Joe Woody, a seasoned healthcare executive and former CEO of Avanos Medical, to its Board of Directors, enhancing the company's strategic and operational expertise.


Key Events · Executive and Board Changes · RCEL

  • New Director Appointment

    Joe Woody was appointed to the Board of Directors of AVITA Medical, Inc., effective January 1, 2026, and will serve on all Board committees.

  • Extensive Healthcare Experience

    Mr. Woody brings over two decades of leadership experience in the medical technology sector, including prior roles as CEO of Avanos Medical and President and CEO of Acelity Holdings.

  • Director Compensation

    Mr. Woody will receive an annual cash retainer of $92,500 and an initial equity grant valued at $210,000, comprising stock options and restricted stock units, subject to shareholder approval.

  • Chairman Retirement

    Lou Panaccio, who served as Chairman from July 2014 to August 2025, retired from the Board of Directors.


Analysis · RCEL · Industrial Applications And Services

AVITA Medical has strengthened its Board of Directors with the appointment of Joe Woody, a highly experienced executive from the medical technology sector. Mr. Woody's extensive background, including his tenure as CEO of Avanos Medical and President and CEO of Acelity Holdings, is expected to bring valuable strategic and operational insights to the company. This move is a positive development for AVITA Medical's governance and future strategic direction. Concurrently, long-serving Chairman Lou Panaccio retired, marking a transition in board leadership.

At the time of this filing, RCEL was trading at $3.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $105.8M. The 52-week trading range was $3.25 to $14.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCEL - Latest Insights

RCEL
Jun 05, 2026, 7:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.34
Real-time Price: $4.55 info
Change: +$0.2111 (+5%) info
Market Cap: $141.881M info
RCEL
Jun 05, 2026, 7:24 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $4.34
Real-time Price: $4.55 info
Change: +$0.2111 (+5%) info
Market Cap: $141.881M info
RCEL
Jun 03, 2026, 7:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.02
Real-time Price: $4.55 info
Change: +$0.530 (+13%) info
Market Cap: $141.881M info
RCEL
May 14, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.67
Real-time Price: $4.55 info
Change: -$0.120 (-3%) info
Market Cap: $141.881M info
RCEL
May 14, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.62
Real-time Price: $4.55 info
Change: -$0.0676 (-1%) info
Market Cap: $141.881M info